TherapeuticsMD TXMD
NASDAQ TXMD
$1.90 +0.02 (+1.06%)
At close: Oct 21, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) Short term Debt (2011 - 2022)

Updated

TherapeuticsMD (TXMD) posted Short term Debt of $93.6 million for Q3 2022, up 524.0% from $15 million a year earlier and up 3.1% from the prior quarter.

Analysis

TherapeuticsMD (TXMD) Short term Debt (2011 - 2022) Analysis & Trends

At the end of FY2021, TherapeuticsMD's Short term Debt came in at $188.27 million.

  • Quarterly Short term Debt has run from a low of $5 million in Q1 2021 to a high of $202.86 million in Q1 2022 over five years.
  • According to Business Quant data, Short term Debt for the three prior quarters was $90.78 million (Q2 2022), $202.86 million (Q1 2022) and $188.27 million (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 TherapeuticsMD 21.67 Mn 21.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 93.60 Mn
Jun 30, 2022 90.78 Mn
Mar 31, 2022 202.86 Mn
Dec 31, 2021 188.27 Mn
Sep 30, 2021 15.00 Mn
Jun 30, 2021 10.00 Mn
Mar 31, 2021 5.00 Mn
Mar 31, 2013 100,000.00
Dec 31, 2011 2.15 Mn
API Access

TherapeuticsMD Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=TXMD&period=max&api_key=YOUR_API_KEY